Occudo Quantitative Strategies’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,967
Closed -$274K 854
2023
Q3
$274K Buy
+3,967
New +$283K 0.04% 698
2023
Q2
Sell
-5,837
Closed -$420K 1056
2023
Q1
$420K Sell
5,837
-732
-11% -$56K 0.04% 562
2022
Q4
$490K Buy
+6,569
New +$471K 0.06% 507
2021
Q2
Sell
-5,963
Closed -$530K 901
2021
Q1
$530K Sell
5,963
-859
-13% -$79.4K 0.12% 309
2020
Q4
$642K Buy
+6,822
New +$600K 0.2% 159

Other funds holding CRI

Occudo Quantitative Strategies's CRI Position: Q4 2023 in Review

Occudo Quantitative Strategies sold out of Carter's (CRI) in Q4 2023, closing a stake of 3,967 shares — an estimated $274K sold.

Occudo Quantitative Strategies first reported a position in CRI in Q4 2020 and held it in 5 quarters. The position peaked at $642K in Q4 2020. 320 funds tracked by Wall St. Rank hold CRI as of Q4 2023.

  • Occudo Quantitative Strategies reported no remaining Carter's position as of Q4 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 3,967 Carter's shares in Q4 2023, an estimated $274K.
  • Occudo Quantitative Strategies first reported a position in Carter's in Q4 2020 and held it in 5 quarters.
  • Occudo Quantitative Strategies's Carter's position peaked at $642K in Q4 2020.
  • 320 funds tracked by Wall St. Rank held Carter's as of Q4 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.